| 臺大學術典藏 |
2021-03-02T14:00:05Z |
Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
|
Liu, Yanfang; Tang, Chao Hsiun; Qiu, Hong; Siggins, Sarah; HSIN-AN HOU |
| 國家衛生研究院 |
2022-12-15 |
Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan
|
Huang, WL;Chiang, CL;Wu, CS;Liao, SC;Chien, TH;Tseng, CH;Tang, CH |
| 國立成功大學 |
2020-10-14 |
Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan
|
Lin;Yih-Jyh;Lin;Chia-Ni;Sedghi;Tannaz;Hsu;Sylvia, H.;Gross;Cary, P.;Wang;Jung-Der;Wang;Shi-Yi |
| 臺北醫學大學 |
2012 |
Treatment Patterns of Breast Cancer Patients in Georgia Medicaid: Are Patterns Different for BCCPTA Women?
|
EK, Adams;LN, Chien;Gabram-M, S |
| 臺大學術典藏 |
2019-11-21T12:25:34Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Shen, Li Jiuan; Hsiao, Fei Yuan; Zhao, Zhongyun; Qian, Yi; Fox, Kathleen M.; Wen, Yao Chun; Lin, Lian Yu; Lin, Lian Yu;Wen, Yao Chun;Hsiao, Fei Yuan;Shen, Li Jiuan;Chen, Wen Jone;Fox, Kathleen M.;Qian, Yi;Zhao, Zhongyun;Rane, Pratik P.; Chen, Wen Jone; Rane, Pratik P. |
| 臺大學術典藏 |
2020-02-27T07:42:33Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Hsiao F.-Y.;Rane P.P.;Zhao Z.;Qian Y.;Lin L.-Y.;Shen L.-J.;Fox K.M.;Wen Y.-C.;WEN-JONE CHEN; WEN-JONE CHEN; Wen Y.-C.; Fox K.M.; Shen L.-J.; Lin L.-Y.; Qian Y.; Zhao Z.; Rane P.P.; Hsiao F.-Y. |
| 臺大學術典藏 |
2020-12-04T07:44:28Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Qian Y.; Zhao Z.; Rane P.P.; Hsiao F.-Y.; Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; LIAN-YU LIN |
| 臺大學術典藏 |
2020-12-21T08:16:10Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Hsiao F.-Y.; Rane P.P.; Zhao Z.; Qian Y.; Lin L.-Y.; Shen L.-J.; Fox K.M.; Wen Y.-C.; WEN-JONE CHEN |
| 臺大學術典藏 |
2020 |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; Lin L.-Y.; Qian Y.; Zhao Z.; Rane P.P.; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2020-12-24T03:00:35Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Hsiao F.-Y.; Rane P.P.; Zhao Z.; Qian Y.; Chen W.-J.; Wen Y.-C.; Fox K.M.; LI-JIUAN SHEN; Lin L.-Y. |
| 臺大學術典藏 |
2022-09-06T02:41:47Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; LIAN-YU LIN; Qian Y.; Zhao Z.; Rane P.P.; Hsiao F.-Y. |
| 臺大學術典藏 |
2022-09-19T03:16:39Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; Lin L.-Y.; Qian Y.; Zhao Z.; Rane P.P.; FEI-YUAN HSIAO |
| 臺北醫學大學 |
2014 |
Treatment plan comparison between stereotactic body radiation therapy techniques for prostate cancer: Non-isocentric CyberKnife versus isocentric RapidArc
|
Lin, Yu-Wei;Lin, Kuei-Hua;Ho, Hsiu-Wen;Lin, Hsiu-Man;Lin, Li-Ching;Lee, Steve P.;Chui, Chen-Shou |
| 國立高雄師範大學 |
2002 |
Treatment program planning by speech therapists in Taiwan
|
曾進興; Chin-Hsing Tseng;W. Y. Chang |
| 國立臺灣大學 |
2008 |
Treatment Recommendations of Hospital-Acquired Pneumonia in Asian Countries: First Consensus Report by the Asian Hap Working Group
|
薛博仁; HSUEH, PO-REN |
| 國立成功大學 |
2012-01 |
Treatment response and cognitive impairment in major depression: Association with C-reactive protein
|
Chang, Hui Hua; Lee, I. Hui; Gean, Po Wu; Lee, Sheng-Yu; Chi, Mei Hung; Yang, Yen Kuang; Lu, Ru-Band; Chen, Po See |
| 高雄醫學大學 |
2010 |
Treatment response in Asian HCV: Different to the West
|
余明隆 |
| 臺大學術典藏 |
2020-10-22T07:27:42Z |
Treatment response in patients with moderate-to-severe psoriasis who had inadequate response to prior secukinumab
|
TSEN-FANG TSAI; Chiu T.-S. |
| 臺大學術典藏 |
2021-10-28T07:11:18Z |
Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
|
Chiang C.-Y.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2021-01-06T08:23:27Z |
Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
|
Su Y.;Yao-Hsu Yang;Chiang B.-L.; Su Y.; YAO-HSU YANG; Chiang B.-L. |
| 臺大學術典藏 |
2021-07-02T03:41:22Z |
Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
|
Su Y.; Yang Y.-H.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2020-06-18T08:25:54Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Sui-Yuan Chang;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Tsai M.-S.; SUI-YUAN CHANG; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:13Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Chang S.-Y.;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Shan-Chwen Chang; Tsai M.-S.; Chang S.-Y.; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-06-04T06:23:11Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; Lin S.-W.; CHING-HUA KUO; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:18Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
